Treating treatment-naïve Genotype 1 (G1) chronic Hepatitis C (CHC) patients with dual (Peginterferon/Ribavirin, P/R) or triple (P/R + Protease Inhibitor, PI) therapy in Hungary. An approach with limited financial resources

2012 ◽  
Vol 50 (05) ◽  
Author(s):  
B Hunyady ◽  
M Makara ◽  
J Gervain ◽  
G Horváth ◽  
F Szalay ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Protease Inhibitor ◽  
Chronic Hepatitis C ◽  
Financial Resources ◽  
Triple P ◽  
Genotype 1 ◽  
Treatment Naïve

The value of cure associated with treating treatment‐naïve chronic hepatitis C genotype 1: Are the new all‐oral regimens good value to society?

2016 ◽  
Vol 37 (5) ◽  
pp. 662-668 ◽  
Author(s):  
Zobair M. Younossi ◽  
Haesuk Park ◽  
Douglas Dieterich ◽  
Sammy Saab ◽  
Aijaz Ahmed ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Genotype 1 ◽  
Treatment Naïve

Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C

Gut ◽  
2010 ◽  
Vol 59 (12) ◽  
pp. 1694-1698 ◽  
Author(s):  
Rami Moucari ◽  
Nicole Forestier ◽  
Dominique Larrey ◽  
Dominique Guyader ◽  
Patrice Couzigou ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Insulin Sensitivity ◽  
Protease Inhibitor ◽  
Chronic Hepatitis C ◽  
Genotype 1
Sign in / Sign up

Export Citation Format

Share Document